Form 483

Krishna Aahar, Inc. Form 483, 2016-01-08

FDA issued a Form 483 to Krishna Aahar, Inc. on 2016-01-08 with 9 public-safe observations.

483· Form 483 issuedFoods & Cosmetics9 observations

Krishna Aahar, Inc. · Sayreville, United States · Issued January 8, 2016

Overview

  • 9 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

8 Jan 2016
21 CFR 110.35(a)

Buildings/sanitary

Cited by Jennifer L Custodio, Dhaval H Patel

8 Jan 2016
21 CFR 110.35(a)

Cleaning and sanitizing operations

Cited by Jennifer L Custodio, Dhaval H Patel

8 Jan 2016
21 CFR 110.35(c)

Lack of effective pest exclusion

Cited by Jennifer L Custodio, Dhaval H Patel

8 Jan 2016
21 CFR 110.37(b)(5)

Backflow prevention

Cited by Jennifer L Custodio, Dhaval H Patel

8 Jan 2016
21 CFR 110.37(d)(3)

Self-closing doors

Cited by Jennifer L Custodio, Dhaval H Patel

Inspected site

KAKrishna Aahar, Inc.Sayreville, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 110.35(a)Cited across public-safe Form 483 observations2x
21 CFR 110.35(c)Cited across public-safe Form 483 observations1x
21 CFR 110.37(b)(5)Cited across public-safe Form 483 observations1x
21 CFR 110.37(d)(3)Cited across public-safe Form 483 observations1x
21 CFR 110.37(e)(5)Cited across public-safe Form 483 observations1x
21 CFR 110.37(f)Cited across public-safe Form 483 observations1x
21 CFR 110.40(a)Cited across public-safe Form 483 observations1x
21 CFR 110.80(a)(1)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere